Ameritas Investment Partners’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$451K Buy
11,713
+429
+4% +$15.8K 0.01% 874
2025
Q4
$401K Buy
11,284
+445
+4% +$12.5K 0.01% 890
2025
Q3
$156K Hold
10,839
﹤0.01% 1389
2025
Q2
$77.8K Buy
10,839
+1,543
+17% +$8.55K ﹤0.01% 1910
2025
Q1
$55.7K Hold
9,296
﹤0.01% 2048
2024
Q4
$72.5K Hold
9,296
﹤0.01% 1967
2024
Q3
$100K Buy
9,296
+1,167
+14% +$11.4K ﹤0.01% 1778
2024
Q2
$68.5K Hold
8,129
﹤0.01% 1963
2024
Q1
$54.6K Hold
8,129
﹤0.01% 2096
2023
Q4
$47.8K Hold
8,129
﹤0.01% 2191
2023
Q3
$79.3K Buy
8,129
+2,435
+43% +$28.9K ﹤0.01% 1815
2023
Q2
$67.4K Buy
5,694
+675
+13% +$7.74K ﹤0.01% 1859
2023
Q1
$54.2K Hold
5,019
﹤0.01% 1932
2022
Q4
$67K Hold
5,019
﹤0.01% 1862
2022
Q3
$74K Buy
5,019
+2,106
+72% +$28.9K ﹤0.01% 1706
2022
Q2
$26K Hold
2,913
﹤0.01% 2409
2022
Q1
$22K Hold
2,913
﹤0.01% 2513
2021
Q4
$25K Hold
2,913
﹤0.01% 2532
2021
Q3
$24K Hold
2,913
﹤0.01% 2596
2021
Q2
$24K Buy
+2,913
New +$24.6K ﹤0.01% 2643
2019
Q2
Sell
-69
Closed -$1K 3056
2019
Q1
$1K Hold
69
﹤0.01% 2963
2018
Q4
$1K Hold
69
﹤0.01% 2979
2018
Q3
$3K Hold
69
﹤0.01% 2985
2018
Q2
$4K Buy
+69
New +$3.32K ﹤0.01% 2951

Other funds holding COGT

Ameritas Investment Partners's COGT Position: Q1 2026 in Review

Ameritas Investment Partners increased its Cogent Biosciences (COGT) stake by 3.8% in Q1 2026, buying an estimated $15.8K and bringing the position to 11,713 shares worth $451K. The position accounts for 0.01% of the portfolio, ranked #874.

Ameritas Investment Partners first reported a position in COGT in Q2 2018 and has held it in 24 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Ameritas Investment Partners held 11,713 shares of Cogent Biosciences worth $451K as of Q1 2026.
  • Ameritas Investment Partners bought 429 Cogent Biosciences shares in Q1 2026, an estimated $15.8K.
  • Cogent Biosciences made up 0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #874 holding.
  • Ameritas Investment Partners first reported a position in Cogent Biosciences in Q2 2018 and has held it in 24 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.